ARKG
ARKG
About ARK Genomic Revolution ETF
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various...
About ARK Genomic Revolution ETF
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 TXG | 10x Genomics, Inc. | 7.90% | 3.07M | $128.31M |
 TEM | Tempus AI, Inc. | 7.74% | 2.25M | $125.69M |
 TWST | Twist Bioscience Corporation | 7.41% | 1.33M | $120.37M |
 PSNL | Personalis, Inc. | 6.70% | 7.24M | $108.83M |
 CRSP | CRISPR Therapeutics AG | 6.31% | 2.02M | $102.49M |
 ABSI | Absci Corporation | 6.19% | 9.84M | $100.48M |
 GH | Guardant Health, Inc. | 4.41% | 452.50K | $71.68M |
 LLY | Eli Lilly and Company | 4.39% | 60.36K | $71.34M |
 BEAM | Beam Therapeutics Inc. | 4.22% | 2.21M | $68.54M |
 ILMN | Illumina, Inc. | 4.18% | 357.13K | $67.87M |
 NTRA | Natera, Inc. | 4.01% | 238.36K | $65.05M |
 VCYT | Veracyte, Inc. | 3.01% | 849.76K | $48.84M |
 CDNA | CareDx, Inc | 2.94% | 1.66M | $47.81M |
 CMPS | COMPASS Pathways plc | 2.86% | 3.52M | $46.47M |
 RXRX | Recursion Pharmaceuticals, Inc. | 2.75% | 13.52M | $44.62M |
 BFLY | Butterfly Network, Inc. | 2.36% | 4.74M | $38.36M |
 NRIX | Nurix Therapeutics, Inc. | 2.34% | 1.67M | $37.92M |
 NTLA | Intellia Therapeutics, Inc. | 2.33% | 2.90M | $37.76M |
 ADPT | Adaptive Biotechnologies Corporation | 2.28% | 1.76M | $37.03M |
 SDGR | Schrödinger, Inc. | 2.05% | 2.03M | $33.27M |
SECTOR HOLDINGS
Healthcare
Technology
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
United States
Switzerland
United KingdomSECTOR HOLDINGS
Healthcare Technology Financial Services Cash & OthersASSET ALLOCATION BY REGION
United States Switzerland United KingdomHoldings (Top 20)
TXG
10x Genomics, Inc.
TEM
Tempus AI, Inc.
TWST
Twist Bioscience Corporation
PSNL
Personalis, Inc.
CRSP
CRISPR Therapeutics AG
ABSI
Absci Corporation
GH
Guardant Health, Inc.
LLY
Eli Lilly and Company
BEAM
Beam Therapeutics Inc.
ILMN
Illumina, Inc.
NTRA
Natera, Inc.
VCYT
Veracyte, Inc.
CDNA
CareDx, Inc
CMPS
COMPASS Pathways plc
RXRX
Recursion Pharmaceuticals, Inc.
BFLY
Butterfly Network, Inc.
NRIX
Nurix Therapeutics, Inc.
NTLA
Intellia Therapeutics, Inc.
ADPT
Adaptive Biotechnologies Corporation
SDGR
Schrödinger, Inc.